Targeted therapies: BREAKing a path for progress--dabrafenib confirms class effect

Nat Rev Clin Oncol. 2012 Sep;9(9):496-7. doi: 10.1038/nrclinonc.2012.138. Epub 2012 Aug 14.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Disease Progression
  • Humans
  • Imidazoles / therapeutic use*
  • Melanoma / drug therapy*
  • Melanoma / genetics
  • Oximes / therapeutic use*
  • Proto-Oncogene Proteins B-raf / genetics*

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Oximes
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • dabrafenib